Biodexa Pharmaceuticals Plc (BDRX)
1.32
-0.19
(-12.58%)
USD |
NASDAQ |
May 01, 16:00
1.33
+0.01
(+0.76%)
After-Hours: 20:00
Biodexa Pharmaceuticals Cash from Investing (TTM): -0.3289M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3289M |
| June 30, 2023 | -0.2137M |
| December 31, 2022 | -0.2601M |
| June 30, 2022 | -0.198M |
| December 31, 2021 | -0.3821M |
| June 30, 2021 | 3.307M |
| December 31, 2020 | 3.403M |
| June 30, 2020 | -3.759M |
| December 31, 2019 | -4.901M |
| June 30, 2019 | 10.79M |
| Date | Value |
|---|---|
| December 31, 2018 | 11.61M |
| June 30, 2018 | -0.7799M |
| December 31, 2017 | -1.892M |
| June 30, 2017 | -2.297M |
| December 31, 2016 | -1.609M |
| June 30, 2016 | -2.068M |
| December 31, 2015 | -2.336M |
| June 30, 2015 | -2.181M |
| December 31, 2014 | -1.459M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.901M
Minimum
Dec 2019
10.79M
Maximum
Jun 2019
0.7455M
Average
-0.2369M
Median
Cash from Investing (TTM) Benchmarks
| Adaptimmune Therapeutics PLC | 176.54M |
| NuCana PLC | 3.594M |
| Autolus Therapeutics PLC | -10.99M |
| Mereo BioPharma Group PLC | -0.419M |
| Bicycle Therapeutics PLC | -2.929M |